| UniProt ID | TAF11_HUMAN | |
|---|---|---|
| UniProt AC | Q15544 | |
| Protein Name | Transcription initiation factor TFIID subunit 11 | |
| Gene Name | TAF11 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 211 | |
| Subcellular Localization | Nucleus. | |
| Protein Description | Core TAFII present in both of the previously described TFIID species which either lack or contain TAFII30 (TFIID alpha and TFIID beta respectively).. | |
| Protein Sequence | MDDAHESPSDKGGETGESDETAAVPGDPGATDTDGIPEETDGDADVDLKEAAAEEGELESQDVSDLTTVEREDSSLLNPAAKKLKIDTKEKKEKKQKVDEDEIQKMQILVSSFSEEQLNRYEMYRRSAFPKAAIKRLIQSITGTSVSQNVVIAMSGISKVFVGEVVEEALDVCEKWGEMPPLQPKHMREAVRRLKSKGQIPNSKHKKIIFF | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 1 | Acetylation | -------MDDAHESP -------CCCCCCCC | 10.70 | 20068231 | |
| 7 | Phosphorylation | -MDDAHESPSDKGGE -CCCCCCCCCCCCCC | 21.60 | 29255136 | |
| 9 | Phosphorylation | DDAHESPSDKGGETG CCCCCCCCCCCCCCC | 62.32 | 29255136 | |
| 60 | Phosphorylation | AEEGELESQDVSDLT HHHCCCCCCCHHHCC | 44.28 | 26657352 | |
| 64 | Phosphorylation | ELESQDVSDLTTVER CCCCCCHHHCCCEEC | 34.88 | 21815630 | |
| 67 | Phosphorylation | SQDVSDLTTVEREDS CCCHHHCCCEECCCC | 33.51 | 28348404 | |
| 68 | Phosphorylation | QDVSDLTTVEREDSS CCHHHCCCEECCCCC | 27.89 | 27251275 | |
| 74 | Phosphorylation | TTVEREDSSLLNPAA CCEECCCCCCCCHHH | 20.38 | 21815630 | |
| 75 | Phosphorylation | TVEREDSSLLNPAAK CEECCCCCCCCHHHH | 49.55 | 21815630 | |
| 82 | Acetylation | SLLNPAAKKLKIDTK CCCCHHHHHCCCCHH | 61.82 | 26051181 | |
| 105 | Ubiquitination | VDEDEIQKMQILVSS CCHHHHHHHHHHHHC | 38.13 | 29967540 | |
| 111 | Phosphorylation | QKMQILVSSFSEEQL HHHHHHHHCCCHHHH | 23.40 | 24719451 | |
| 112 | Phosphorylation | KMQILVSSFSEEQLN HHHHHHHCCCHHHHH | 25.88 | 28348404 | |
| 114 | Phosphorylation | QILVSSFSEEQLNRY HHHHHCCCHHHHHHH | 42.02 | 28348404 | |
| 121 | Phosphorylation | SEEQLNRYEMYRRSA CHHHHHHHHHHHHCC | 12.18 | 30206219 | |
| 124 | Phosphorylation | QLNRYEMYRRSAFPK HHHHHHHHHHCCCCH | 7.31 | 30206219 | |
| 131 | Ubiquitination | YRRSAFPKAAIKRLI HHHCCCCHHHHHHHH | 43.95 | - | |
| 155 | Phosphorylation | QNVVIAMSGISKVFV CCEEEEECCCCEEHH | 24.77 | 24400094 | |
| 158 | Phosphorylation | VIAMSGISKVFVGEV EEEECCCCEEHHHHH | 26.71 | 24400094 | |
| 204 | Acetylation | KGQIPNSKHKKIIFF CCCCCCCCCCCEEEC | 67.11 | 7692113 | |
| 206 | Acetylation | QIPNSKHKKIIFF-- CCCCCCCCCEEEC-- | 49.78 | 7692121 | |
| 207 | Acetylation | IPNSKHKKIIFF--- CCCCCCCCEEEC--- | 40.53 | 7692129 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of TAF11_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of TAF11_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TAF11_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| TAF13_HUMAN | TAF13 | physical | 7729427 | |
| TBP_HUMAN | TBP | physical | 7729427 | |
| TBP_HUMAN | TBP | physical | 8670810 | |
| TAF13_HUMAN | TAF13 | physical | 9695952 | |
| LZTR1_HUMAN | LZTR1 | physical | 20211142 | |
| NFYB_HUMAN | NFYB | physical | 11689552 | |
| NFYC_HUMAN | NFYC | physical | 11689552 | |
| VDR_HUMAN | VDR | physical | 10744685 | |
| THA_HUMAN | THRA | physical | 10744685 | |
| RPB1_HUMAN | POLR2A | physical | 15502823 | |
| ACTB_HUMAN | ACTB | physical | 15502823 | |
| TBP_HUMAN | TBP | physical | 10591645 | |
| A4_HUMAN | APP | physical | 21832049 | |
| APBP2_HUMAN | APPBP2 | physical | 25416956 | |
| TAF13_HUMAN | TAF13 | physical | 29111974 | |
| TAF7_HUMAN | TAF7 | physical | 29111974 | |
| TAF1_HUMAN | TAF1 | physical | 29111974 | |
| TAF2_HUMAN | TAF2 | physical | 29111974 | |
| TAF3_HUMAN | TAF3 | physical | 29111974 | |
| TAF4_HUMAN | TAF4 | physical | 29111974 | |
| TAF4B_HUMAN | TAF4B | physical | 29111974 | |
| TAF5_HUMAN | TAF5 | physical | 29111974 | |
| TAF6_HUMAN | TAF6 | physical | 29111974 | |
| TAF8_HUMAN | TAF8 | physical | 29111974 | |
| TAF9_HUMAN | TAF9 | physical | 29111974 | |
| TAF9B_HUMAN | TAF9B | physical | 29111974 | |
| TAF10_HUMAN | TAF10 | physical | 29111974 | |
| TAF11_HUMAN | TAF11 | physical | 29111974 | |
| TAF12_HUMAN | TAF12 | physical | 29111974 | |
| TBP_HUMAN | TBP | physical | 29111974 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND MASS SPECTROMETRY. | |
| Phosphorylation | |
| Reference | PubMed |
| "ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage."; Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.; Science 316:1160-1166(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-60, AND MASSSPECTROMETRY. | |